BEIJING, Sept. 19, 2024 (GLOBE NEWSWIRE) — Haoxi Health Technology Limited (“Company” or “HAO”), an online marketing solutions provider headquartered in Beijing, China, today announced the of its social order. offering (“Offering”) of 4,000,000 units (each a “Unit,” and collectively, “Units”) at a price of $3.00 per Unit (the “Offering Price”) for a total of the total amount of $12,000,000, before withdrawal. underwriting discounts and other issuance costs. Each Unit consists of (i) one share of Class A Common Share, par value $0.0001 per share (“Class A Common Share”) (or warrant to purchase a Class A Common Share” “)), (ii) one Series A warrant to purchase a Class A Common Share (“Series A Warrant”) (subject to and certain modifications thereto), and (iii) the issuance of one Series B Warrant to purchase such number of Class A Common Shares as described in the Offering (the “Series B Warrant”, together with the Series B Warrant A, “Warrants”). The Warrants will have a term of 5 years from the closing date of the Offering (the “Exemption Date”).th) calendar day from the Closing Date (the “Series B Training Date”). The Series A Warrants have an initial exercise price of $3.00 per Class A Common Share. On the Series B Exercise Date, the exercise price of the Series A Warrant will be adjusted to $0.60 and the maximum number of The Class A Common Shares issuable upon exercise of the Series A Warrants will be converted into 20,000,000 shares. The exercise price of the Series B Warrants is $0.0001 per Class A Common Share. The maximum number of shares issuable upon exercise of the Series B Warrants will be 16,000,000 shares. Units have no independent rights and cannot be certificated or issued as individual securities. The Class A Common Shares, Cash-Backed Notes, and related Notes are immediately divisible and will be issued separately in the Offering.
The offering is made with a solemn vow. The Company has granted to EF Hutton LLC (“EF Hutton”), the underwriter, an option, within 45 days from the Closing Date, to purchase an additional 600,000 shares at a Public Offering Price, at a discount of text, to cover the full amount. -distribution option.
The offering is expected to close on or about September 20, 2024, subject to the satisfaction of customary closing conditions.
EF Hutton is the sole bookmaker for the Offering. Hunter Taubman Fischer & Li LLC is acting as US counsel to the Company, and Pryor Cashman LLP is US counsel to EF Hutton, in connection with the Offering.
The Company intends to use the proceeds of this Offering for 1) working capital and general business purposes; 2) acquiring or investing in technologies, solutions or businesses; and 3) hiring experienced staff.
A registration statement on Form F-1 (File No. 333-280174) relating to the Offering, as amended, has been filed with the US Securities and Exchange Commission (“SEC”), and has been declared effective by SEC on September 19. , 2024. The offering is made only by prospectus. Copies of the final prospectus relating to the Offering may be obtained from EF Hutton, Attn: Syndicate Department, 590 Madison Avenue, 39th Floor, New York, NY 10022, or by email at syndicate@efhutton.com or by phone at (212) 404-7002. In addition, a copy of the final prospectus may also be obtained through the SEC’s website at www.sec.gov.
Before investing, you should read the prospectus and other documents that the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor will there be any sale of these securities in any place or location any where such offer, solicitation or sale may be lawful before that. to be registered or qualified under the securities laws of any such country or jurisdiction.
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a Beijing-based China-headquartered e-commerce solution provider, specializing in serving customers in the healthcare industry. The Company’s growth is driven by the rise of media advertising and the rapid development of the healthcare sector. The company provides a one-stop internet marketing solution, mainly in online short video marketing, helping advertisers to find and retain customers on popular Chinese platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It is dedicated to reducing costs, increasing efficiency, and providing simple internet marketing solutions to marketers. For more information, please visit: http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking statements. Forward-looking statements include statements about plans, objectives, goals, strategies, future events or performance, and underlying assumptions and statements other than statements of historical fact. When the Company uses words such as “may,” “will,” “expect,” “should,” “believe,” “anticipate,” “anticipate,” “plan,” “estimate” or similar expressions that are not . in historical matters, it makes forward-looking statements. These forward-looking statements include, without limitation, the Company’s statements regarding the expected trading of its Common Shares on the Nasdaq Capital Market and the closing of the Offering. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual results to differ from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, uncertainties related to market conditions and the completion of the initial public offering on expected terms or at all, and factors some of which are discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance on any forward-looking statements contained in this press release. Additional information is discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
The underwriter
EF Hutton LLC
Ms. Stephanie Hu, Head of Asia, Investment Banking
Email:syndicate@efhutton.com
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Operations Manager
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214
#Haoxi #Health #Technology #Limited #Announces #Underwritten #Public #Offering #Prices #Million